Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Fox

Showing results (71-80 of 258) with videos related to

Pageof 26
Sort By:
BMC Medical Genomics|March 29, 2022
Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnosticsKenneth D Doig, Christopher G Love, Thomas Conway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapseGaynor J Bates, Stephen B Fox, Cheng Han, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2014
Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancerSiddhartha Deb, Ida Johansson, David Byrne, et al.
BMC Cancer|September 13, 2017
BRCA2 carriers with male breast cancer show elevated tumour methylationSiddhartha Deb, Kylie L Gorringe, Jia-Min B Pang, et al.
Breast Cancer Research : BCR|December 22, 2007
Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancerErn Yu Tan, Leticia Campo, Cheng Han, et al.
Pathology|March 12, 2014
HER2 status in gastric/gastro-oesophageal junctional cancers: should determination of gene amplification by SISH use HER2 copy number or HER2: CEP17 ratio?Marian Priyanthi Kumarasinghe, Willem Bastiaan de Boer, Tze Sheng Khor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancerErn Yu Tan, Leticia Campo, Cheng Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancerJane L Boddy, Stephen B Fox, Cheng Han, et al.
The Prostate|May 5, 2007
Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxiaAlison H Banham, Jane Boddy, Rosalind Launchbury, et al.
BMC Bioinformatics|December 17, 2017
Canary: an atomic pipeline for clinical amplicon assaysKenneth D Doig, Jason Ellul, Andrew Fellowes, et al.
Pageof 26

Showing results (71-80 of 258) with videos related to

Sort By:
Pageof 26
BMC Medical Genomics|March 29, 2022
Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnosticsKenneth D Doig, Christopher G Love, Thomas Conway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapseGaynor J Bates, Stephen B Fox, Cheng Han, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2014
Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancerSiddhartha Deb, Ida Johansson, David Byrne, et al.
BMC Cancer|September 13, 2017
BRCA2 carriers with male breast cancer show elevated tumour methylationSiddhartha Deb, Kylie L Gorringe, Jia-Min B Pang, et al.
Breast Cancer Research : BCR|December 22, 2007
Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancerErn Yu Tan, Leticia Campo, Cheng Han, et al.
Pathology|March 12, 2014
HER2 status in gastric/gastro-oesophageal junctional cancers: should determination of gene amplification by SISH use HER2 copy number or HER2: CEP17 ratio?Marian Priyanthi Kumarasinghe, Willem Bastiaan de Boer, Tze Sheng Khor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancerErn Yu Tan, Leticia Campo, Cheng Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancerJane L Boddy, Stephen B Fox, Cheng Han, et al.
The Prostate|May 5, 2007
Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxiaAlison H Banham, Jane Boddy, Rosalind Launchbury, et al.
BMC Bioinformatics|December 17, 2017
Canary: an atomic pipeline for clinical amplicon assaysKenneth D Doig, Jason Ellul, Andrew Fellowes, et al.
Pageof 26